Systematic Investigation of Genetic Vulnerabilities Across Cancer Cell Lines Reveals Lineage-Specific Dependencies in Ovarian Cancer
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer Hiu Wing Cheunga,b,1, Glenn S. Cowleyb,1, Barbara A. Weirb,1, Jesse S. Boehmb,1, Scott Rusinb, Justine A. Scottb, Alexandra Eastb, Levi D. Alib, Patrick H. Lizotteb, Terence C. Wongb, Guozhi Jiangb, Jessica Hsiaob, Craig H. Mermela,b,c, Gad Getzb, Jordi Barretinaa,b, Shuba Gopalb, Pablo Tamayob, Joshua Gouldb, Aviad Tsherniakb, Nicolas Stranskyb, Biao Luob, Yin Rend, Ronny Drapkine,f, Sangeeta N. Bhatiab,d,g,h,i, Jill P. Mesirovb, Levi A. Garrawaya,b,c,g, Matthew Meyersona,b,c,e, Eric S. Landerb,2, David E. Rootb,2, and William C. Hahna,b,c,g,2 aDepartment of Medical Oncology, cCenter for Cancer Genome Discovery and fCenter for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02115; bBroad Institute of Harvard and MIT, Cambridge, MA 02142; dHarvard-MIT Division of Health Sciences and Technology and hElectrical Engineering and Computer Science, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Departments of ePathology and gMedicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and iHoward Hughes Medical Institute, Chevy Chase, MD 20815 Contributed by Eric S. Lander, June 13, 2011 (sent for review April 13, 2011) A comprehensive understanding of the molecular vulnerabilities A major feature of ovarian cancers is recurrent regions of of every type of cancer will provide a powerful roadmap to guide copy-number alteration (1). A small number of these recurrent therapeutic approaches. Efforts such as The Cancer Genome Atlas genomic events harbor known oncogenes and tumor suppressor Project will identify genes with aberrant copy number, sequence, genes, such as MYC, CCNE1, and RB (2).
[Show full text]